XMT-1592

N/A

Report date: 2024/03/16 20:00:47

Base Information

Drug NameXMT-1592

Drug Alias NameXMT-1592

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAF payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionSodium-dependent phosphate transport protein 2B inhibitors

TargetsSodium-dependent phosphate transport protein 2B

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMersana Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMersana Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Other Information

ATC CodeN/A